BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Immunology Podcast - ECPv6.16.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The Immunology Podcast
X-ORIGINAL-URL:https://www.immunologypodcast.com
X-WR-CALDESC:Events for The Immunology Podcast
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220607
DTEND;VALUE=DATE:20220608
DTSTAMP:20230120T171634Z
CREATED:20220525T183149Z
LAST-MODIFIED:20230120T171634Z
UID:3977-1654560000-1654646399@www.immunologypodcast.com
SUMMARY:Dr. Hanover Matz
DESCRIPTION:Dr. Hanover Matz is a Postdoctoral Researcher at the University of Maryland. His PhD research focused mainly on the basic biology of the shark B cell response\, and how the humoral immune system evolved in vertebrates. He also uses the IgNAR immunoglobulin isotype in sharks to address applied questions\, primarily generating shark antibodies as diagnostic/therapeutic tools. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-hanover-matz
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2022/05/Matz_headshot-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220524
DTEND;VALUE=DATE:20220525
DTSTAMP:20230120T171620Z
CREATED:20220407T161940Z
LAST-MODIFIED:20230120T171620Z
UID:3902-1653350400-1653436799@www.immunologypodcast.com
SUMMARY:Dr. Michael Alonso
DESCRIPTION:Dr. Michael Alonso is a Scientific Co-Founder\, and Vice President of Immunology & Pharmacology at Bolt Biotherapeutics\, a biotechnology company developing immunotherapies that activate myeloid cells. This includes immune-stimulating antibody conjugates (ISAC)\, which reprogram the tumor microenvironment to invoke a new anti-tumor immune response. Dr. Alonso has a PhD in Immunology from Stanford University School of Medicine\, where his research demonstrated that activated T cells dictate the nature of the immune response by instructing monocytes to differentiate into specialized dendritic cell subsets. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-michael-alonso
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2022/04/Michael-Alonso.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220510
DTEND;VALUE=DATE:20220511
DTSTAMP:20230120T171605Z
CREATED:20220507T153104Z
LAST-MODIFIED:20230120T171605Z
UID:3942-1652140800-1652227199@www.immunologypodcast.com
SUMMARY:Dr. Alice Long
DESCRIPTION:Dr. S. Alice Long is an Associate Member of the Center for Translational Immunology at Benaroya Research Institute at Virginia Mason. The Long lab is focused on understanding how tolerance is lost in autoimmunity. Gaining a better understanding of the disease-related causes and consequences of defective cytokine signaling may lead to development of more sensitive biomarkers and more targeted therapies that promote tolerance. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-alice-long
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2022/05/Headshot-Long-S.-Alice.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220508
DTEND;VALUE=DATE:20220509
DTSTAMP:20230120T171551Z
CREATED:20220507T152455Z
LAST-MODIFIED:20230120T171551Z
UID:3939-1651968000-1652054399@www.immunologypodcast.com
SUMMARY:Dr. Shruti Naik
DESCRIPTION:Dr. Shruti Naik is an Assistant Professor of Biological Sciences at NYU Langone. She studies immunity in the epithelial tissues that line our body to understand how environmental stimuli collaborate with genetic factors to influence health and drive disease at these interfaces. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-shruti-naik
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2022/05/naiks06-hero.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220506
DTEND;VALUE=DATE:20220507
DTSTAMP:20230120T171538Z
CREATED:20220506T204752Z
LAST-MODIFIED:20230120T171538Z
UID:3936-1651795200-1651881599@www.immunologypodcast.com
SUMMARY:Dr. Gwendalyn Randolph
DESCRIPTION:Dr. Gwendalyn Randolph is the Emil R. Unanue Distinguished Professor in the Department of Immunology and Pathology at Washington University in St. Louis. Research in her lab integrates the study of monocytes\, monocyte-derived cells\, and dendritic cells with vascular and lymphatic vessel biology. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-gwendalyn-randolph
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2022/05/Gwendalyn-Randolph.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220426
DTEND;VALUE=DATE:20220427
DTSTAMP:20230120T171949Z
CREATED:20220310T204418Z
LAST-MODIFIED:20230120T171949Z
UID:3859-1650931200-1651017599@www.immunologypodcast.com
SUMMARY:Dr. Michael Rosenblum
DESCRIPTION:Dr. Michael Rosenblum is a Professor of Dermatology at the University of California\, San Francisco. The central focus of his lab’s research is to understand how immune responses are regulated in tissues and how this knowledge can be exploited for therapeutic benefit. They are currently investigating how regulatory T cells (Tregs) control immune responses in tissues\, and their “alternative” functions. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-michael-rosenblum
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2022/03/Rosenblum-Headshot-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220412
DTEND;VALUE=DATE:20220413
DTSTAMP:20230120T172001Z
CREATED:20220330T235933Z
LAST-MODIFIED:20230120T172001Z
UID:3893-1649721600-1649807999@www.immunologypodcast.com
SUMMARY:Dr. Gary Koretzky
DESCRIPTION:Dr. Gary Koretzky is the President of the American Association of Immunologists (AAI). He is also the Vice Provost for Academic Integration at  Cornell University\, Professor of Medicine at Weill Cornell Medicine\, and Director of the Cornell Center for Immunology. This will be a special episode focused on the upcoming AAI 2022 meeting. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-gary-koretzky
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2022/03/Gary-Koretzky-square.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220329
DTEND;VALUE=DATE:20220330
DTSTAMP:20230120T172014Z
CREATED:20211110T223952Z
LAST-MODIFIED:20230120T172014Z
UID:3776-1648512000-1648598399@www.immunologypodcast.com
SUMMARY:Dr. Florian Krammer
DESCRIPTION:Dr. Florian Krammer is a Professor of Virology at the Department of Microbiology at the Icahn School of Medicine at Mount Sinai. His lab studies cross-reactive antibody responses towards viral surface glycoproteins. Their projects include studying cross-reactive antibody responses to viruses\, developing a universal influenza vaccine\, and developing vaccines and antibodies against emerging zoonic viruses.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-florian-krammer
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/11/Florian-Krammer-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220315
DTEND;VALUE=DATE:20220316
DTSTAMP:20230120T172026Z
CREATED:20220313T225404Z
LAST-MODIFIED:20230120T172026Z
UID:3862-1647302400-1647388799@www.immunologypodcast.com
SUMMARY:Drs. Hannah Lee & Andy Kokaji
DESCRIPTION:Dr. Hannah Lee is a Senior Director of Product Management\, and Dr. Andy Kokaji is a Senior Director of Immunology at STEMCELL Technologies\, a company that provides high-quality cell culture media\, cell separation technologies\, instruments\, accessory products\, and educational resources to scientists around the world working on stem cell\, immunology\, cancer\, regenerative medicine\, and cellular therapy research. Dr. Lee has a PhD in microbiology from the University of Toronto\, and her job is to ensure the best products are developed\, manufactured\, marketed\, and delivered to scientific researchers. Dr. Kokaji has a PhD in immunology from the University of Alberta\, and is responsible for product development\, long-term strategy\, and top-level scientific support to customers and collaborators for immunotherapy\, immunology and cell separation product lines.\n \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/drs-hannah-lee-andy-kokaji
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2022/03/Hannah-Lee-and-Andy-Kokaji-square.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220301
DTEND;VALUE=DATE:20220302
DTSTAMP:20230120T172040Z
CREATED:20211103T181112Z
LAST-MODIFIED:20230120T172040Z
UID:3763-1646092800-1646179199@www.immunologypodcast.com
SUMMARY:Dr. Jennifer Gommerman
DESCRIPTION:Dr. Jennifer Gommerman is a Professor and Associate Chair of Graduate Studies in the Department of Immunology at the University of Toronto. She also holds the Canada Research Chair in Tissue-Specific Immunity. Her lab studies the mechanisms of immune dysregulation in autoimmune disease\, particularly multiple sclerosis. They are interested in the high prevalence of autoimmune disease in Canada and the role of TNF family members. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-jennifer-gommerman
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2021/11/Headshot-June-2020-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220215
DTEND;VALUE=DATE:20220216
DTSTAMP:20230120T172053Z
CREATED:20220209T002634Z
LAST-MODIFIED:20230120T172053Z
UID:3835-1644883200-1644969599@www.immunologypodcast.com
SUMMARY:Dr. Caetano Reis e Sousa
DESCRIPTION:Dr. Caetano Reis e Sousa is the Assistant Research Director and Senior Group Leader at the Francis Crick Institute. Dr. Reis e Sousa’s lab studies the molecular pathways that trigger dendritic cells into action.  He has helped to define the cells and pathways involved in innate immune detection of RNA viruses\, fungi and dead cells. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-caetano-reis-e-sousa
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2022/02/Caetano-Reis-e-Sousa-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220201
DTEND;VALUE=DATE:20220202
DTSTAMP:20230120T172105Z
CREATED:20211220T224859Z
LAST-MODIFIED:20230120T172105Z
UID:3806-1643673600-1643759999@www.immunologypodcast.com
SUMMARY:Dr. Francesco Colucci
DESCRIPTION:Dr. Francesco Colucci is a Wellcome Investigator and Professor of Immunology at the University of Cambridge. Dr. Colucci’s research focuses on natural killer and other innate lymphoid cells\, as well as immunogenetics. His group specifically explores the role of uterine immune cells in pregnancy\, and aims to improve immunotherapies by comparing and contrasting uterine NK cells with tumor-infiltrating NK cells. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-francesco-colucci
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2021/12/Francesco-Colucci.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220119
DTEND;VALUE=DATE:20220120
DTSTAMP:20230120T172118Z
CREATED:20220113T173006Z
LAST-MODIFIED:20230120T172118Z
UID:3821-1642550400-1642636799@www.immunologypodcast.com
SUMMARY:Dr. Mihai Netea
DESCRIPTION:Dr. Mihai Netea is a Professor of Experimental Medicine at Radboud University. He aims to understand factors influencing the variability of human immune responses\, the biology of sepsis and immunoparalysis in bacterial and fungal infections\, and the memory traits of innate immunity. His recent research involves BCG vaccination and trained immunity. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-mihai-netea
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2022/01/Photo-Mihai-Netea.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211221
DTEND;VALUE=DATE:20211222
DTSTAMP:20230120T172131Z
CREATED:20211217T233851Z
LAST-MODIFIED:20230120T172131Z
UID:3804-1640044800-1640131199@www.immunologypodcast.com
SUMMARY:Dr. De'Broski Herbert
DESCRIPTION:Dr. De’Broski Herbert is an Associate Professor of Immunology at the University of Pennsylvania. The Herbert lab is exploring the immunoregulatory and regenerative mechanisms operating at the mucosal interface. They employ a combination of molecular and biochemical approaches to interrogate cellular immunity under steady-state and infectious conditions. His lab recently published a paper on IL-33 expression in anti-helminth immunity. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-debroski-herbert
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/12/headshot-4.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211207
DTEND;VALUE=DATE:20211208
DTSTAMP:20230120T172145Z
CREATED:20211127T001234Z
LAST-MODIFIED:20230120T172145Z
UID:3787-1638835200-1638921599@www.immunologypodcast.com
SUMMARY:Dr. Keke Fairfax
DESCRIPTION:Dr. Keke Fairfax is an Associate Professor of Microbiology and Immunology and Director of Equity\, Diversity\, and Inclusion at the University of Utah. Her lab uses helminth parasite Schistosoma mansoni as a tool to understand both the consequences of IL-4 induced immuno-modulation\, and the complex interplay between B\, T\, and stromal cells necessary to develop an optimal T and B cell memory response. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-keke-fairfax
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/11/fairfax-keke.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211123
DTEND;VALUE=DATE:20211124
DTSTAMP:20230120T172544Z
CREATED:20211103T182801Z
LAST-MODIFIED:20230120T172544Z
UID:3766-1637625600-1637711999@www.immunologypodcast.com
SUMMARY:Dr. Tri Phan
DESCRIPTION:Dr. Tri Phan is a Conjoint Professor at the University of New South Wales and Senior Principal Research Fellow at the Garvan Institute of Medical Research. He heads the Intravital Microscopy and Gene Expression (IMAGE) Lab\, which studies B cell dynamics and fate in immunity\, autoimmunity\, cancer and primary immunodeficiency diseases. His group tracks the dynamics of antigen-specific B cells in order to understand the checks and balances that control the output from the immune response. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-tri-phan
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/11/Tri-Phan.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211109
DTEND;VALUE=DATE:20211110
DTSTAMP:20230120T172531Z
CREATED:20210819T193458Z
LAST-MODIFIED:20230120T172531Z
UID:3721-1636416000-1636502399@www.immunologypodcast.com
SUMMARY:Dr. Jenny Ting
DESCRIPTION:Dr. Jenny P. Y. Ting is a William R Kenan Jr. Distinguish Professor at the University of North Carolina at Chapel Hill. Her lab studies the biological effects of NLR proteins in disease. Additional projects involve the microbiome\, neuroinflammation\, an immune activating microparticle delivery system\, and mitigation of radiation induced toxicity. She served as the President of the American Association of Immunologists from 2020-2021. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-jenny-ting
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/08/Ting-Headshot.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211026
DTEND;VALUE=DATE:20211027
DTSTAMP:20230120T172519Z
CREATED:20210721T190530Z
LAST-MODIFIED:20230120T172519Z
UID:3699-1635206400-1635292799@www.immunologypodcast.com
SUMMARY:Dr. Dario Vignali
DESCRIPTION:Dr. Dario Vignali is the Frank Dixon Chair in Cancer Immunology and Vice Chair and Professor of Immunology at University of Pittsburgh School of Medicine. His lab studies various aspects of T cell regulation and function focusing on mechanisms and diseases. His lab recently published a paper examining how B cell signatures and tertiary lymphoid structures affect outcomes in head and neck squamous cell carcinoma. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-dario-vignali
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/07/Dario-Vignali-square.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211012
DTEND;VALUE=DATE:20211013
DTSTAMP:20230120T172504Z
CREATED:20210928T171431Z
LAST-MODIFIED:20230120T172504Z
UID:3741-1633996800-1634083199@www.immunologypodcast.com
SUMMARY:Dr. Anil Bhushan
DESCRIPTION:Dr. Anil Bhushan is a Professor at the University of California\, San Francisco. His lab focuses on understanding how the immune system senses and tunes its response to senescent cells in disease and aging. His lab was one of the first to show the role of clearing senescent cells in models of Type 1 diabetes. They are interested in identifying and targeting the endogenous immune surveillance mechanism that can promote elimination of senescent cells and reverse disease progression. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-anil-bhushan
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/09/Anil-Bhushan-Square.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210928
DTEND;VALUE=DATE:20210929
DTSTAMP:20230120T172450Z
CREATED:20210708T214636Z
LAST-MODIFIED:20230120T172450Z
UID:3687-1632787200-1632873599@www.immunologypodcast.com
SUMMARY:Dr. Michael Burton
DESCRIPTION:Dr. Michael Burton is an Assistant Professor at the University of Texas in Dallas. His lab studies the complex interactions between the immune and nervous systems that lead to pain\, depression\, and sickness\, with special interests in the influence of age and the endogenous cannabinoid system. He believes in order to traverse the gap between basic research and clinical application to the patient\, we must realize and appreciate pre-clinical research. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-michael-burton
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/07/Michael-Burton-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210914
DTEND;VALUE=DATE:20210915
DTSTAMP:20230120T172438Z
CREATED:20210708T211123Z
LAST-MODIFIED:20230120T172438Z
UID:3684-1631577600-1631663999@www.immunologypodcast.com
SUMMARY:Dr. Frances Lund
DESCRIPTION:Dr. Frances Lund is the Charles H. McCauley Professor and Chair of the Department of Microbiology at the University of Alabama at Birmingham. Dr. Lund is most well known for the work from her laboratory showing that B lymphocytes have a larger role in the immune response than previously appreciated. While scientists have long recognized that B cells make antibodies that label bacteria and viruses for destruction by the immune system\, Dr. Lund’s group showed that B cells also produce chemical signaling molecules called cytokines and demonstrated that the cytokines made specifically by B cells can alter the magnitude\, duration and quality of the immune response that is generated in response to pathogens\, allergens and autoantigens. Today her laboratory focuses on developing methods to identify and eliminate B cells that contribute to autoimmune or allergic disease pathogenesis while maintaining the protective pathogen-specific B cell subsets. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-frances-lund
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/07/Frances-Lund-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210831
DTEND;VALUE=DATE:20210901
DTSTAMP:20230120T172425Z
CREATED:20210824T194933Z
LAST-MODIFIED:20230120T172425Z
UID:3724-1630368000-1630454399@www.immunologypodcast.com
SUMMARY:Dr. Jeffrey Bluestone
DESCRIPTION:Dr. Jeffrey Bluestone is the CEO and President of Sonoma Biotherapeutics\, which is leveraging the properties of regulatory T cells to create living cell therapies that restore the immune system back to its balanced\, fully functioning state. He was previously a Professor at the Diabetes Center at the University of California San Francisco\, and his research over the past 25 years has focused on understanding the basic processes that control T cell activation and immune tolerance in autoimmunity and organ transplantation. \n  \nImage by Steve Babuljak\, courtesy of Dr. Jeff Bluestone \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-jeffrey-bluestone
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/08/jeffrey-bluestone-portrait.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210817
DTEND;VALUE=DATE:20210818
DTSTAMP:20230120T172408Z
CREATED:20210708T205331Z
LAST-MODIFIED:20230120T172408Z
UID:3681-1629158400-1629244799@www.immunologypodcast.com
SUMMARY:Dr. Christopher Klebanoff
DESCRIPTION:Dr. Christopher Klebanoff is a medical oncologist and translational researcher whose focus is on providing the best care possible to people with breast cancer. He is a member of the Center for Cell Engineering and the Parker Institute for Cancer Immunotherapy at the Memorial Sloan Kettering Cancer Center\, and is particularly interested in cell-based cancer immunotherapies\, T cell receptors\, and the therapeutic targeting of shared cancer neoantigens. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-christopher-klebanoff
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/07/Christopher-Klebanoff.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210803
DTEND;VALUE=DATE:20210804
DTSTAMP:20230120T172355Z
CREATED:20210611T220237Z
LAST-MODIFIED:20230120T172355Z
UID:3666-1627948800-1628035199@www.immunologypodcast.com
SUMMARY:Dr. James Crowe
DESCRIPTION:Dr. James Crowe is the Director of the Vanderbilt Vaccine Center. Their group uses a very broad array of techniques including molecular and cellular biology\, state-of-the-art imaging and flow cytometry\, bioinformatics\, and bioengineering approaches to attack the scientific problems that are of interest to them: major human pathogens. These pathogens include respiratory syncytial virus\, human metapneumovirus\, rotavirus\, HIV\, influenza\, and vaccinia virus. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-james-crowe
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2021/06/James-Crowe.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210720
DTEND;VALUE=DATE:20210721
DTSTAMP:20230120T172341Z
CREATED:20210611T211007Z
LAST-MODIFIED:20230120T172341Z
UID:3662-1626739200-1626825599@www.immunologypodcast.com
SUMMARY:Dr. Marc Jenkins
DESCRIPTION:Dr. Marc Jenkins is a Regents and Distinguished McKnight University Professor  in the Department of Microbiology and Immunology at the University of Minnesota. The Jenkins lab is focused on the basic biology of CD4+ T lymphocytes. They investigate CD4+ T and B cell activation in vivo by directly tracking antigen-specific cells. The goal of this research is a basic understanding of lymphocyte activation that can be used to improve vaccines and prevent autoimmunity. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-marc-jenkins
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/06/Marc-Jenkins-Square.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210706
DTEND;VALUE=DATE:20210707
DTSTAMP:20230120T173323Z
CREATED:20210611T195501Z
LAST-MODIFIED:20230120T173323Z
UID:3655-1625529600-1625615999@www.immunologypodcast.com
SUMMARY:Dr. Robyn Hall
DESCRIPTION:Dr. Robyn Hall is a Research Scientist and Team Leader at the Commonwealth Scientific and Industrial Research Organisation (CSIRO). Her current research is focused on understanding the epidemiology of lagoviruses in the Australian landscape and how they interact with each other\, understanding the fundamental biology of these viruses\, and investigating the ways in which these viruses evolve. She is particularly interested in the role of recombination in the evolution of the caliciviruses. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-robyn-hall
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/06/robyn-hall-square.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210622
DTEND;VALUE=DATE:20210623
DTSTAMP:20230120T173309Z
CREATED:20210519T173503Z
LAST-MODIFIED:20230120T173309Z
UID:3633-1624320000-1624406399@www.immunologypodcast.com
SUMMARY:Drs. Isaac Chiu and Tiphaine Voisin
DESCRIPTION:Dr. Isaac Chiu is an Assistant Professor in the Department of Immunology at Harvard Medical School. His research focuses on interactions between the nervous system\, immune system\, and microbes in pain\, host defense and inflammation. Dr. Tiphaine Voisin is a former postdoctoral fellow in the Chiu lab whose project focused on the role of cysteinyl leukotrienes in chronic itch. \nRead their recent PNAS paper on chronic itch. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/drs-isaac-chiu-and-tiphaine-voisin
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2021/05/Isaac-Chiu-and-Tiphaine-Voisin.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210608
DTEND;VALUE=DATE:20210609
DTSTAMP:20230120T173255Z
CREATED:20210224T215017Z
LAST-MODIFIED:20230120T173255Z
UID:3530-1623110400-1623196799@www.immunologypodcast.com
SUMMARY:Dr. Daniela Thommen
DESCRIPTION:Dr. Daniela Thommen is a Group Leader at the Netherlands Cancer Institute. Her lab is interested in understanding how human cancers immunologically respond to treatment\, and how such responses relate to the immunological makeup of a tumor. \nListen to the episode here. \n 
URL:https://www.immunologypodcast.com/upcoming-guests/dr-daniela-thommen
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2021/02/Daniela-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210525
DTEND;VALUE=DATE:20210526
DTSTAMP:20230120T173240Z
CREATED:20210224T223509Z
LAST-MODIFIED:20230120T173240Z
UID:3536-1621900800-1621987199@www.immunologypodcast.com
SUMMARY:Dr. Judy Lieberman and Dr. Caroline Junqueira
DESCRIPTION:Dr. Judy Lieberman is a Professor of Pediatrics at Harvard Medical School and holds an endowed chair in Cellular and Molecular Medicine at Boston Children’s Hospital. Dr. Caroline Junqueira is an Investigator at the Oswaldo Cruz Foundation and a visiting scientist at Harvard Medical School. Both researchers are interested in cytotoxic T lymphocytes — key cells in the immune defense against viral infection and cancer. \nRead their recent Nature Immunology paper showing that activated γδ T cells suppress Plasmodium falciparum blood-stage infection by direct killing and phagocytosis here. \nListen to the episode here. \n  \n 
URL:https://www.immunologypodcast.com/upcoming-guests/dr-judy-lieberman-and-dr-caroline-junqueira
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/05/Judy-and-Caroline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210511
DTEND;VALUE=DATE:20210512
DTSTAMP:20230120T173227Z
CREATED:20210224T221138Z
LAST-MODIFIED:20230120T173227Z
UID:3533-1620691200-1620777599@www.immunologypodcast.com
SUMMARY:Dr. Carl June and Dr. Philipp Rommel
DESCRIPTION:Dr. Carl June is the Richard W. Vague Professor in Immunology at the University of Pennsylvania\, Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine\, and Director of the Parker Institute for Cancer Immunotherapy. Dr. Philipp Rommel is a Postdoctoral Researcher in the June lab. Together\, they are interested in lymphocyte biology\, with a major translational focus on ex vivo T-cell engineering for cancer and HIV cell-based therapies. \nListen to the episode here. \n  \n 
URL:https://www.immunologypodcast.com/upcoming-guests/dr-carl-june-and-dr-philipp-rommel
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2021/02/Carl-and-Philipp-1.png
END:VEVENT
END:VCALENDAR